MSF Responds to new WHO guidance recommending vastly shorter, improved and better tolerated treatment for multi drug-resistant TB
Médecins Sans Frontières/Doctors Without Borders (MSF) are pleased that, having shared the results of TB-PRACTECAL, our clinical trial that found a new, safer and more effective six-month oral treatm... read more